|
WO2020085504A1
(ja)
|
2018-10-26 |
2020-04-30 |
大鵬薬品工業株式会社 |
光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
|
|
CN114867726B
(zh)
|
2019-10-28 |
2023-11-28 |
默沙东有限责任公司 |
Kras g12c突变体的小分子抑制剂
|
|
US12479834B2
(en)
|
2019-11-29 |
2025-11-25 |
Taiho Pharmaceutical Co., Ltd. |
Phenol compound or salt thereof
|
|
CN116368130A
(zh)
|
2020-08-28 |
2023-06-30 |
金橘生物科技公司 |
杂环化合物及其用途
|
|
IL305568A
(en)
*
|
2021-03-12 |
2023-10-01 |
Bristol Myers Squibb Co |
KRAS G12D inhibitors
|
|
JP2024517695A
(ja)
*
|
2021-04-29 |
2024-04-23 |
アムジエン・インコーポレーテツド |
複素環式化合物及び使用方法
|
|
JP2024517693A
(ja)
*
|
2021-04-29 |
2024-04-23 |
アムジエン・インコーポレーテツド |
２－アミノベンゾチアゾール化合物及びその使用方法
|
|
CN117500799A
(zh)
*
|
2021-06-09 |
2024-02-02 |
伊莱利利公司 |
作为kras g12d抑制剂的取代的稠合吖嗪
|
|
EP4373822A2
(en)
*
|
2021-07-23 |
2024-05-29 |
Theras Inc. |
Compositions and methods for inhibition of ras
|
|
US20240409558A1
(en)
*
|
2021-09-13 |
2024-12-12 |
Biomea Fusion, Inc. |
Irreversible inhibitors of kras
|
|
WO2023061294A1
(zh)
*
|
2021-10-13 |
2023-04-20 |
再鼎医药(上海)有限公司 |
含氮杂环类衍生物调节剂、其制备方法及应用
|
|
WO2023072188A1
(zh)
*
|
2021-10-29 |
2023-05-04 |
贝达药业股份有限公司 |
Kras g12d抑制剂及其在医药上的应用
|
|
WO2023103523A1
(zh)
*
|
2021-12-09 |
2023-06-15 |
苏州浦合医药科技有限公司 |
取代的双环杂芳基化合物作为kras g12d抑制剂
|
|
WO2023114733A1
(en)
*
|
2021-12-13 |
2023-06-22 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
AR128212A1
(es)
*
|
2022-01-06 |
2024-04-10 |
Theras Inc |
Composiciones y métodos para la inhibición de ras
|
|
WO2023133183A1
(en)
*
|
2022-01-06 |
2023-07-13 |
Theras, Inc. |
Kras inhibitors
|
|
CN118556063A
(zh)
*
|
2022-01-21 |
2024-08-27 |
上海湃隆生物科技有限公司 |
杂环类化合物、药物组合物及其应用
|
|
MX2024008849A
(es)
|
2022-01-21 |
2024-07-25 |
Usynova Pharmaceuticals Ltd |
Compuestos de benzopirimidina y uso de estos.
|
|
IL314486A
(en)
*
|
2022-02-03 |
2024-09-01 |
Mirati Therapeutics Inc |
Quinazoline compounds inhibit PAN-KRAS
|
|
AU2023218370B2
(en)
|
2022-02-09 |
2024-11-28 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
EP4479398A1
(en)
*
|
2022-02-16 |
2024-12-25 |
Amgen Inc. |
Quinazoline compounds and use thereof as inhibtors of mutant kras proteins
|
|
AU2023222076A1
(en)
*
|
2022-02-16 |
2024-08-15 |
Amgen Inc. |
Quinazoline compounds and use thereof as inhibtors of mutant kras proteins
|
|
KR20240163107A
(ko)
|
2022-03-11 |
2024-11-18 |
컴쿼트 바이오사이언시즈 인크. |
헤테로환 화합물 및 이의 용도
|
|
CN118900838A
(zh)
*
|
2022-03-24 |
2024-11-05 |
百济神州有限公司 |
杂环化合物、其组合物及其治疗方法
|
|
CN116891488B
(zh)
*
|
2022-04-11 |
2025-12-12 |
成都海博为药业有限公司 |
稠环化合物、包含其的药物组合物及应用
|
|
WO2023225252A1
(en)
*
|
2022-05-20 |
2023-11-23 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|
|
IL317601A
(en)
|
2022-05-25 |
2025-02-01 |
Quanta Therapeutics Inc |
Pyrimidine-based modulators and their uses
|
|
WO2023246777A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Jacobio Pharmaceuticals Co., Ltd. |
K-ras mutant protein inhibitors
|
|
JP2025524597A
(ja)
*
|
2022-07-07 |
2025-07-30 |
ベイジン スウィッツアランド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
複素環式化合物、その組成物、及びそれによる処置方法
|
|
CA3261681A1
(en)
|
2022-08-05 |
2024-02-08 |
Kumquat Biosciences Inc. |
HETEROCYCLIC COMPOUNDS AND THEIR USES
|
|
WO2024030647A1
(en)
|
2022-08-05 |
2024-02-08 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|
|
JP2025525938A
(ja)
*
|
2022-08-05 |
2025-08-07 |
セラス， インコーポレイテッド |
Ｋｒａｓの阻害のための組成物及び方法
|
|
WO2024044667A2
(en)
*
|
2022-08-26 |
2024-02-29 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of kras proteins
|
|
WO2024063576A1
(ko)
*
|
2022-09-23 |
2024-03-28 |
일동제약(주) |
Kras 저해 물질로서 신규한 퀴나졸린 화합물
|
|
CN120077051A
(zh)
*
|
2022-10-21 |
2025-05-30 |
苏州亚盛药业有限公司 |
Kras抑制剂
|
|
EP4598921A1
(en)
*
|
2022-11-14 |
2025-08-13 |
Amgen Inc. |
Macrocyclic kras inhibitors and methods of use
|
|
CN116554208A
(zh)
*
|
2022-12-02 |
2023-08-08 |
苏州浦合医药科技有限公司 |
取代的双环杂芳基化合物作为kras g12d抑制剂
|
|
CN116082115A
(zh)
*
|
2023-01-06 |
2023-05-09 |
河南省科学院化学研究所有限公司 |
一种2-溴-4-氯-9,9’-二甲基芴的合成方法
|
|
WO2024192424A1
(en)
|
2023-03-15 |
2024-09-19 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2024206747A1
(en)
*
|
2023-03-30 |
2024-10-03 |
Eli Lilly And Company |
Kras inhibitors
|
|
WO2024243025A1
(en)
*
|
2023-05-19 |
2024-11-28 |
Ikena Oncology, Inc. |
Naphthyl-substituted pyrido[4,3-d]pyrimidines and related compounds and their use in treating medical conditions
|
|
CN119219661A
(zh)
*
|
2023-06-29 |
2024-12-31 |
西藏海思科制药有限公司 |
一种5元杂芳基衍生物及其在医药上的应用
|
|
WO2025019823A1
(en)
*
|
2023-07-20 |
2025-01-23 |
Merck Sharp & Dohme Llc |
Small molecule protein degraders of kras g12d mutant
|
|
WO2025049402A1
(en)
*
|
2023-08-28 |
2025-03-06 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
WO2025051242A1
(zh)
*
|
2023-09-08 |
2025-03-13 |
泰励生物科技（上海）有限公司 |
Ras抑制剂
|
|
AU2024337913A1
(en)
|
2023-09-08 |
2026-03-26 |
Gilead Sciences, Inc. |
Pyrimidine-containing polycyclic derivatives as kras g12d modulating compounds
|
|
TW202523324A
(zh)
*
|
2023-10-08 |
2025-06-16 |
大陸商成都海博為藥業有限公司 |
一種稠環化合物及應用
|
|
US20250114339A1
(en)
|
2023-10-09 |
2025-04-10 |
Incyte Corporation |
Combination therapy comprising a kras g12d inhibitor and an egfr inhibitor
|
|
AU2024357850A1
(en)
|
2023-10-09 |
2026-04-23 |
Incyte Corporation |
Combination therapy using a kras g12d inhibitor and pd-1 inhibitor or pd-l1 inhibitor
|
|
WO2025085748A1
(en)
|
2023-10-20 |
2025-04-24 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of kras proteins
|
|
WO2025090811A1
(en)
*
|
2023-10-25 |
2025-05-01 |
Kumquat Biosciences Inc. |
Methods of modulating cell proliferation
|
|
WO2025117828A1
(en)
*
|
2023-12-01 |
2025-06-05 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|